British American Tobacco, R&D, Southampton, Hampshire, SO15 8TL, UK.
British American Tobacco, R&D, Southampton, Hampshire, SO15 8TL, UK.
Food Chem Toxicol. 2020 Nov;145:111713. doi: 10.1016/j.fct.2020.111713. Epub 2020 Sep 28.
Tobacco-free 'modern' oral nicotine pouches (MOPs), are similar in appearance and use to Swedish-style snus, but without tobacco. There are few identified methods to create test samples for toxicologically assessment of MOPs in vitro. In this study we present a simple method for the extraction of pouch material in cell culture media, providing consistent nicotine concentration and easy in vitro assessment. A series of contemporary in vitro screening assays (viability, cell health markers, oxidative stress and genotoxicity) using human oral fibroblasts (HGF) and human lung epithelial cells (H292) were employed. Extracts were generated from LYFT and compared to snus (CRP1.1) and cigarette (1R6F) reference products. MOP and CRP1.1 extracts were generated by incubating one pouch in 20 ml of cell culture media, while 1R6F AqE was prepared by smoking 1 cigarette into 20 ml of cell culture media. 1R6F demonstrated toxicological responses in most assays; CRP1.1 had minimal to moderate effects while MOP demonstrated little or no response in all assays. This study demonstrated the generation of MOPs extracts and their toxicological evaluation using in vitro screening approaches. Future product usage, pharmacokinetics and clinical studies will further substantiate the reduced risk potential of MOPs.
无烟草“现代”口含烟(MOP)在外观和使用上类似于瑞典式鼻烟,但不含烟草。目前很少有确定的方法可以为 MOP 的毒理学体外评估创建测试样本。在这项研究中,我们提出了一种从细胞培养介质中提取烟袋材料的简单方法,可提供一致的尼古丁浓度和易于进行体外评估。使用人口腔成纤维细胞(HGF)和人肺上皮细胞(H292)进行了一系列当代体外筛选检测(活力、细胞健康标志物、氧化应激和遗传毒性)。从 LYFT 中提取了提取物,并与鼻烟(CRP1.1)和香烟(1R6F)参考产品进行了比较。通过将一个烟袋在 20ml 细胞培养液中孵育来生成 MOP 和 CRP1.1 提取物,而 1R6F AqE 是通过将 1 支香烟抽吸到 20ml 细胞培养液中制备的。1R6F 在大多数检测中表现出毒理学反应;CRP1.1 的影响最小到中度,而 MOP 在所有检测中几乎没有反应或没有反应。本研究证明了 MOP 提取物的生成及其使用体外筛选方法进行的毒理学评估。未来的产品使用、药代动力学和临床研究将进一步证实 MOP 的潜在低风险。